Journal article
Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53
I Fillippovich, N Sorokina, M Gatei, Y Haupt, K Hobson, E Moallem, K Spring, M Mould, MA Mcguckin, MF Lavin, KK Khanna
Oncogene | NATURE PUBLISHING GROUP | Published : 2001
Abstract
p73 has recently been identified as a structural and functional homolog of the tumor suppressor protein p53. Overexpression of p53 activates transcription of p53 effector genes, causes growth inhibition and induced apoptosis. We describe here the effects of a tumor-derived truncated transcript of p73α (p73Δexon2) on p53 function and on cell death. This transcript, which lacks the acidic N-terminus corresponding to the transactivation domain of p53, was initially detected in a neuroblastoma cell line. Overexpression of p73Δexon2 partially protects lymphoblastoid cells against apoptosis induced by anti-Fas antibody or cisplatin. By cotransfecting p73Δexon2 with wild-type p53 in the p53 null li..
View full abstract